Cargando…

Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies

To determine the efficacy of intratympanic OTO-104 for the treatment of Ménière's disease. STUDY DESIGNS: Three randomized, double-blind, placebo-controlled, multicenter studies of OTO-104 in patients with Ménière's disease. SETTING: The United States and throughout Europe. PATIENTS: Indiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, John, Mikulec, Anthony A., Robinson, James M., Skarinsky, David, Anderson, Jeffery J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Vestibular Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289225/ https://www.ncbi.nlm.nih.gov/pubmed/37185596 http://dx.doi.org/10.1097/MAO.0000000000003886

Ejemplares similares

Efficacy and Safety of Intranasal Betahistine in the Treatment of Surgery-Induced Acute Vestibular Syndrome: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study
por: Van de Heyning, Paul, et al.
Publicado: (2023)

Vestibular Aqueduct Morphology Correlates With Endolymphatic Sac Pathologies in Menière's Disease—A Correlative Histology and Computed Tomography Study
por: Bächinger, David, et al.
Publicado: (2019)

A randomized, double-blind, placebo-controlled phase 2 study of intratympanic OTO-313 in patients with moderate to severe subjective tinnitus
por: Searchfield, Grant D., et al.
Publicado: (2023)

Longitudinal Cognitive and Neurobehavioral Functional Outcomes Before and After Repairing Otic Capsule Dehiscence
por: Wackym, P. Ashley, et al.
Publicado: (2016)

Steroids for Acute Vestibular Neuronitis—the Earlier the Treatment, the Better the Outcome?
por: Sjögren, Julia, et al.
Publicado: (2019)

Sémont Maneuver for Benign Paroxysmal Positional Vertigo Treatment: Moving in the Correct Plane Matters
por: Gebhart, Isabel, et al.
Publicado: (2021)

Vestibular Complaints Impact on the Long-Term Quality of Life of Vestibular Schwannoma Patients
por: Fuentealba-Bassaletti, Constanza, et al.
Publicado: (2023)

Influence of the Electrode Montage to Detect Ocular Vestibular Evoked Myogenic Potentials
por: Mat, Quentin, et al.
Publicado: (2023)

Characteristics and Possible Mechanisms of Direction-Reversing Nystagmus During Positional Testing in Patients With Benign Paroxysmal Positional Vertigo
por: Li, Xiang, et al.
Publicado: (2023)

Intratympanic corticosteroids for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Intratympanic gentamicin for Ménière’s disease
por: Webster, Katie E, et al.
Publicado: (2023)

Visual effects on the subjective visual vertical and subjective postural head vertical during static roll‐tilt
por: Tamura, Atsushi, et al.
Publicado: (2017)

Consensus on intratympanic drug delivery for Menière’s disease
por: Li, Shuna, et al.
Publicado: (2022)

Editorial: Intratympanic and surgical treatment for Meniere's disease
por: Yang, Jun, et al.
Publicado: (2022)

Intratympanic Administration of OTO-313 Reduces Tinnitus in Patients With Moderate to Severe, Persistent Tinnitus: A Phase 1/2 Study
por: Maxwell, Kenneth S., et al.
Publicado: (2021)

Intratympanic gentamicin treatment for Ménière’s disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study
por: Bremer, Hendrik G, et al.
Publicado: (2014)

Intratympanic corticosteroids in Ménière's disease: A mini-review
por: Patel, Mitesh
Publicado: (2017)

Efficacy and Durability of Intratympanic Gentamicin Treatment for Meniere's Disease
por: Guan, Yafeng, et al.
Publicado: (2021)

Intratympanic gentamycine for Ménière’s disease: is there a selective vestibulotoxic effect?
por: Molnár, András, et al.
Publicado: (2020)

Quality of life after intratympanic steroid injection for Ménière's disease
por: Schenck, Annejet A., et al.
Publicado: (2022)

Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
por: Memari, Faramarz, et al.
Publicado: (2014)

Duration of symptom control following intratympanic dexamethasone injections in Meniere’s disease
por: Hilton, Aidan, et al.
Publicado: (2022)

Intratympanic Sustained-Exposure Dexamethasone Thermosensitive Gel for Symptoms of Ménière's Disease: Randomized Phase 2b Safety and Efficacy Trial
por: Lambert, Paul R., et al.
Publicado: (2016)

Correction: Effect of Intratympanic Dexamethasone on Controlling Tinnitus and Hearing loss in Meniere’s Disease
Publicado: (2014)

Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
por: Yetişer, Sertaç
Publicado: (2018)

MRI With Intratympanic Gadolinium: Comparison Between Otoneurological and Radiological Investigation in Menière's Disease
por: Neri, Giampiero, et al.
Publicado: (2021)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Therapeutic Effect of Intratympanic Injection of Dexamethasone plus Hyaluronic Acid on Patients with Meniere's disease
por: Rogha, Mehrdad, et al.
Publicado: (2019)

Intratympanic Injection of Dexamethasone and Electrocochleographic Data in Cases of Definite One Sided Refractory Meniere’s Disease
por: Dabiri Satri, Sasan, et al.
Publicado: (2017)

Effectiveness of intratympanic dexamethasone for the treatment of vertigo attacks in patients with Ménière’s disease compared with betahistine pharmacotherapy
por: Molnár, András, et al.
Publicado: (2021)

Botulinum neurotoxin treatment in jerky and tremulous functional movement disorders: a double-blind, randomised placebo-controlled trial with an open-label extension
por: Dreissen, Yasmine Emma Maria, et al.
Publicado: (2019)

Effect of tranexamic acid on intraoperative blood loss in pediatric osteotomies around the hip: Study protocol for a double-blind randomized placebo-controlled trial
por: van Kouswijk, Hilde W, et al.
Publicado: (2023)

One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings
por: Daneshi, Ahmad, et al.
Publicado: (2014)

Use of Skull Vibration-Induced Nystagmus in the Follow-up of Patients With Ménière Disease Treated With Intratympanic Gentamicin
por: Alonso, Susana Marcos, et al.
Publicado: (2023)

Dynamic Change of VOR and Otolith Function in Intratympanic Gentamicin Treatment for Ménière's Disease: Case Report and Review of the Literature
por: Walther, L. E., et al.
Publicado: (2013)

Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
por: Schoenfeld, Philip, et al.
Publicado: (2018)

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo‐controlled, randomized, double‐blinded, parallel‐group comparison/open‐label clinical trial
por: Hyodo, Masamitsu, et al.
Publicado: (2021)

Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, randomized withdrawal study in adults with narcolepsy with cataplexy
por: Bogan, Richard K, et al.
Publicado: (2020)

Comparison of the diagnostic value of 3 T MRI after intratympanic injection of GBCA, electrocochleography, and the glycerol test in patients with Meniere's disease
por: Fukuoka, Hisakuni, et al.
Publicado: (2012)

Intratympanic steroids injection is effective for the treatment of drop attacks with Ménière's disease and delayed endolymphatic hydrops: A retrospective study
por: Liu, Bo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_c0cgnmf6a7qqtnmgec7mdkns6f